WallStreetZenWallStreetZen

NASDAQ: SCNI
Scinai Immunotherapeutics Ltd Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

SCNI earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$11.0M
Current Profit Margin
0%

SCNI Return on Equity

Current Company
N/A
Current Industry
15.4%
Current Market
-8.4%

Be the first to know when SCNI announces earnings.

SCNI Return on Assets

Current Company
-49.3%
Current Industry
2.2%
SCNI is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

SCNI Return on Capital Employed

Current Company
-84.38%
Current Industry
17.7%
SCNI's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SCNI vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
SCNI$0.00N/A-$10.95MN/AN/A
BPTH$0.00-$15.90M-$16.08MN/AN/A
DRMA$0.00-$7.79M-$7.79MN/AN/A
INM$5.49M-$5.75M-$6.35M+354.96%N/A
QLGN$0.00-$11.89M-$13.42M-100.00%N/A
View Top Biotech Stocks

Scinai Immunotherapeutics Earnings & Revenue FAQ

What were SCNI's earnings last quarter?

Scinai Immunotherapeutics (NASDAQ: SCNI) reported Q3 2023 earnings per share (EPS) of -$0.80, up 80% year over year. Total Scinai Immunotherapeutics earnings for the quarter were -$3.11 million. In the same quarter last year, Scinai Immunotherapeutics's earnings per share (EPS) was -$4.00.

If you're new to stock investing, here's how to buy Scinai Immunotherapeutics stock.

What was SCNI's earnings growth in the past year?

As of Q2 2024, Scinai Immunotherapeutics's earnings has grown year over year. Scinai Immunotherapeutics's earnings in the past year totalled -$10.95 million.

What was SCNI's revenue last quarter?

Scinai Immunotherapeutics (NASDAQ: SCNI) reported Q3 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Scinai Immunotherapeutics's revenue was $0.00.

What was SCNI's revenue growth in the past year?

As of Q2 2024, Scinai Immunotherapeutics's revenue has grown null year over year. Scinai Immunotherapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.